Product description

Favipiravir 400 Mg Tablet
for use in mild to moderate
covid-19 in india
Rapidily reduce the viral load
offers broad spectrum RNA virus coverage.
Faster symptomatic and radiological improvement.
Shows 80% efficasy in cobid-19 patients.
Respiratory failure
Coronary thrombosis
oxygen demand / hypoxia
Acute Respiratory distress
superimposed infection lung

Total Daily Dose
Day 1- 1800mg BID
Day 2 to max 14 days 800 mg BID